← Back to Search

Corticosteroid

NSAID for Glaucoma

N/A
Waitlist Available
Led By Graham Trope, MD FRCSC
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 - 85 years of age
Undergoing glaucoma drainage device surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up six weeks
Awards & highlights

Study Summary

This study aims to evaluate the eye pressure response to non-steroidal anti-inflammatory eye drops as compared to steroid eye drops following glaucoma surgery.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~six weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and six weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intraocular pressure

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: NSAIDExperimental Treatment1 Intervention
Group II: SteroidsActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,460 Previous Clinical Trials
483,308 Total Patients Enrolled
6 Trials studying Glaucoma
212 Patients Enrolled for Glaucoma
Graham Trope, MD FRCSCPrincipal InvestigatorUniversity Health Network, Toronto

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Mar 2025